Publication:
Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect

dc.contributor.authorÖZBAŞ, SUNA
dc.contributor.authorsOzbas-Turan, S.; Akbuga, J.; Enneli, B.
dc.date.accessioned2022-03-12T17:38:20Z
dc.date.accessioned2026-01-10T17:22:50Z
dc.date.available2022-03-12T17:38:20Z
dc.date.issued2009
dc.description.abstractThe objective of this study was to investigate the effect of different formulation parameters [i.e. molecular weight and concentration of chitosan, concentration of tripolyphosphate (TPP) and use of alginate] on physico chemical and antisense properties of antisense oligonucleotide (AsODN) loaded chitosan nanoparticles (NPs). Preparation methods of phosphodiester (PO) and phosphorothioate (PS) AsODNs-NPs were also compared. AsODNI was designed to target the beta-galactosidase (beta-gal) gene. HeLa cells were used for in vitro transfection studies and beta-gal was assayed spectrophotometrically. AsODN-NPs obtained were in general positively charged with size between 221.4-525.7 nm depending on formulation. Encapsulation efficiency of NPs depended on the type of backbone of the AsODN. PO-AsODN encapsulation into NPs (78-94%) was less efficient than PS encapsulation (91-98%). The pH of the chitosan solution affected AsODN entrapment. PO-NPs exhibited faster AsODN release than NPs containing PS. In general higher beta-gal inhibition was obtained after transfection of AsODN-NPs in cell culture studies. PS-NPs exhibited a higher inhibition effect and the highest (90.71%) inhibition was obtained with formulation PT-2. PS-adsorbed NPs showed an 88% reduction in beta-gal. This study can form the basis for forthcoming in vivo studies related to AsODN carrier systems that will use chitosan.
dc.identifier.doi10.1691/ph.2009.9193
dc.identifier.issn0031-7144
dc.identifier.pubmed20095138
dc.identifier.urihttps://hdl.handle.net/11424/229472
dc.identifier.wosWOS:000274307300005
dc.language.isoeng
dc.publisherGOVI-VERLAG PHARMAZEUTISCHER VERLAG GMBH
dc.relation.ispartofPHARMAZIE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPOLYALKYLCYANOACRYLATE NANOPARTICLES
dc.subjectGENE DELIVERY
dc.subjectFORMULATION
dc.subjectSYSTEM
dc.subjectINHIBITION
dc.subjectCARRIERS
dc.subjectDNA
dc.titleEvaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage811
oaire.citation.issue12
oaire.citation.startPage807
oaire.citation.titlePHARMAZIE
oaire.citation.volume64

Files